Forzest — Research Summary
Forzest 20 mg by Ranbaxy is a pharmaceutical-grade tadalafil citrate formulation designed for in-vitro research applications. Tadalafil is a potent phosphodiesterase type 5 (PDE-5) inhibitor that researchers frequently study for its vasodilatory mechanisms and cyclic guanosine monophosphate (cGMP) pathway modulation. This compound enables laboratory investigation of endothelial function, smooth muscle relaxation, and nitric oxide signaling pathways in controlled research environments. At Stroid UK Shop, we supply authentic Ranbaxy formulations to support rigorous scientific investigation.
Laboratory Applications
Research teams examine tadalafil’s molecular interactions with cyclic nucleotide phosphodiesterases, particularly its selectivity for PDE-5 compared to other phosphodiesterase enzymes. Laboratory studies investigate the compound’s extended half-life characteristics, bioavailability profiles, and tissue distribution patterns in experimental models. Cardiovascular research utilizes tadalafil to examine pulmonary arterial pressure modulation and vascular smooth muscle function. The compound serves as a valuable tool for studying endothelial nitric oxide synthase (eNOS) pathway enhancement and its downstream effects on vascular tone. Research into erection drugs and tadalafil citrate mechanisms frequently incorporates this formulation. Comparative studies with selective androgen receptor modulators and research peptides provide insights into different molecular pathways affecting cellular function.
Research Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tadalafil Citrate |
| Strength | 20 mg per unit |
| Manufacturer | Ranbaxy |
| CAS Number | 171596-29-5 (tadalafil) |
| Molecular Formula | C₂₂H₁₉N₃O₄ |
| Molecular Weight | 389.40 g/mol |
| Storage | Room temperature, dry conditions |
| Solubility | Verify with supplier documentation |
Research Compliance Statement
Forzest 20 mg Ranbaxy is supplied exclusively for in-vitro laboratory research purposes. This pharmaceutical compound is intended solely for qualified researchers conducting studies on phosphodiesterase inhibition, vascular biology, and cellular signaling pathways. Not approved for human consumption or clinical application. Researchers must maintain appropriate laboratory protocols and safety measures when handling this research material. All experimental work should follow institutional guidelines for chemical research compounds.
